Christopher J Forlenza

4PUBLICATIONS
41CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedRespiratory diseasesHaematologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 15, 2025
Less may be enough: a transplant-free future for low-risk relapsed Hodgkin lymphoma.

Christopher J Forlenza, Sharon M Castellino

|Mar 10, 2023
Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma.

Christopher J Forlenza, Jaclyn Rosenzweig, Audrey Mauguen

|Feb 01, 2023
Molecular Evolution of Classic Hodgkin Lymphoma Revealed Through Whole-Genome Sequencing of Hodgkin and Reed Sternberg Cells.

Francesco Maura, Bachisio Ziccheddu, Jenny Z Xiang

|Sep 24, 2021
Combination brentuximab vedotin and bendamustine for pediatric patients with relapsed/refractory Hodgkin lymphoma.

Christopher J Forlenza, Nitya Gulati, Audrey Mauguen

Pageof 1